iRadimed IRMD Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $56.37M+12.0% | $51.16M-2.1% | $56.53M+9.3% | $53M+9.2% | $50.33M+11.5% | ||
| $13.42M+5.6% | $13.67M+29.5% | $13.86M+33.7% | $10.92M-8.6% | $12.71M-2.5% | ||
| $12.45M+18.0% | $12.18M+17.0% | $11.73M+4.3% | $11.2M-7.2% | $10.56M-16.9% | ||
| $86.42M+15.0% | $81.2M+7.9% | $84.92M+14.3% | $77.37M+5.2% | $75.14M+4.5% | ||
| $24.23M+18.9% | $23.86M+41.9% | $23.79M+68.1% | $22.94M+119% | $20.38M+116% | ||
| $3.29M+0.8% | $3.38M+9.2% | $3.37M+16.7% | $3.37M+22.8% | $3.26M+22.1% | ||
| $114.39M+12.4% | $108.78M+10.6% | $114.72M+21.7% | $106.45M+18.3% | $101.73M+15.6% | ||
| $2.18M-15.8% | $1.82M-4.0% | $2.33M+66.6% | $1.9M+69.6% | $2.59M+102% | ||
| $3.4M+30.7% | $2.87M+27.0% | $3.16M+23.6% | $3.26M+28.4% | $2.6M+11.1% | ||
| $12.12M+43.0% | $10.18M+19.6% | $12.8M+58.7% | $8.81M+18.2% | $8.47M+11.2% | ||
| $15.88M+36.0% | $14.16M+23.0% | $16.37M+51.4% | $12.15M+18.2% | $11.68M-1.8% | ||
| 31.5M+2,476,315% | 31.5M+3,149,900% | 1.3K+0.4% | 1.3K+0.4% | 1.3K+0.5% | ||
| $67.49M+13.8% | $64.23M+13.1% | $66.34M+23.9% | $62.93M+24.9% | $59.32M+25.2% | ||
| $98.51M+9.4% | $94.62M+9.0% | $98.35M+17.9% | $94.3M+18.4% | $90.05M+18.3% | ||
| $114.39M+12.4% | $108.78M+10.6% | $114.72M+21.7% | $106.45M+18.3% | $101.73M+15.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are iRadimed's total assets?
- iRadimed (IRMD) holds $114.4M in total assets, up 12.4% year over year.
- How much cash does iRadimed have?
- iRadimed holds $56.4M in cash and equivalents.
- Can iRadimed cover its short-term obligations?
- Its current ratio is 7.13 — current assets exceed current liabilities.
- Where does iRadimed's balance sheet data come from?
- Every line is extracted from iRadimed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
